High Net Worth Advisory Group’s Neurocrine Biosciences NBIX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-1,000
| Closed | -$119K | – | 435 |
|
2022
Q4 | $119K | Hold |
1,000
| – | – | 0.05% | 233 |
|
2022
Q3 | $106K | Hold |
1,000
| – | – | 0.05% | 235 |
|
2022
Q2 | $97K | Hold |
1,000
| – | – | 0.04% | 242 |
|
2022
Q1 | $94K | Hold |
1,000
| – | – | 0.03% | 258 |
|
2021
Q4 | $85K | Buy |
+1,000
| New | +$85K | 0.03% | 280 |
|